New Scientist Colab Podcasts

The UK’s energy system is undergoing a quiet revolution. As we move away from fossil fuels towards a cleaner, more flexible, and electrified future, Octopus Energy is helping to turn the traditional power grid on its head. In this episode of New Scientist CoLab, Justin Mullins is joined by Kieron Stopforth, Head of Flexibility at Octopus Energy.  Kieron explains how the way we generate, store and use electricity is changing - and why your home, solar panels, and even your car could be part of the solution. This is a New Scientist CoLab production, sponsored by Octopus Energy. Your host is Justin Mullins. Find out more at newscientist.com/podcasts [http://newscientist.com/podcasts]. Learn more about your ad choices. Visit megaphone.fm/adchoices [https://megaphone.fm/adchoices]

Dementia is the UK’s leading cause of death, and one in three people born today will develop it in their lifetime. With numbers steadily rising, the need for effective treatments and improved dementia diagnosis is more urgent than ever. Thankfully, recent advances in science mean we understand the diseases that cause dementia better than ever. There has never been a more exciting time in dementia research, and supporting some of the most pioneering work in this field is UK charity Alzheimer’s Society. In this episode of the New Scientist CoLab podcast, Justin Mullins is joined by Richard Oakley, Associate Director of Research and Innovation at Alzheimer's Society. Richard explores the latest breakthroughs in dementia treatment and promising areas of research. He discusses the latest technologies and trials that are bringing us closer to a better future for people living with dementia. And he discusses his belief that research, with time, can beat dementia. This is a New Scientist CoLab production, sponsored by Alzheimer’s Society [https://www.alzheimers.org.uk/what-we-do/our-research?utm_source=nichepublication&utm_medium=paid&utm_campaign=42001_w03_rea_newscientistedu_&utm_content=_vanity_newscientistlive__newscientistlive&utm_term=demogeo_broad&utm_source_platform=Paid%20Newspaper%20Ads]. Find out more at newscientist.com/podcasts [http://newscientist.com/podcasts] Learn more about your ad choices. Visit megaphone.fm/adchoices [https://megaphone.fm/adchoices]

What does it take to tackle the world’s most complex diseases? For David Price, head of the Vertex Pharmaceuticals Oxford Research site, the motivation is deeply personal. In this podcast from New Scientist CoLab, David shares his incredible journey and gives a detailed look inside Vertex, the company that pioneered patient-first drug discovery. Learn about their unique serial innovation strategy, which focuses on treating the underlying cause of a disease, not just the symptoms. He also discusses how automation and robotics are transforming the lab and why talented students and interns represent an extraordinary future. Sponsored by Vertex Pharmaceuticals. Learn more about your ad choices. Visit megaphone.fm/adchoices [https://megaphone.fm/adchoices]

Hear an inspiring story of career transformation, leadership, and purpose-driven science. In this special series of New Scientist CoLab interviews, we spotlight exceptional women driving progress in science, technology, engineering, and mathematics. Lorna is a Senior Science Manager at AWE, a technology and security organisation supporting the UK's nuclear deterrent. She’s the Acting Group Leader of Defence Radiation Protection Services at AWE, leading a team of 71 specialists. Lorna’s story is a reminder that STEM careers can begin in the most unexpected places as she shares her unconventional journey into science which began not in a laboratory, but in a classroom as a teacher.   We explore: ●      Lorna’s bold career pivot from education to national defence science ●      How she now delivers radiation protection for MOD operations ●      The value of diverse backgrounds in STEM and her path ●      And her advice for others considering non-traditional paths into science and engineering This series is proudly sponsored by AWE [https://www.awe.co.uk/]. Your host is Claire Aisnworth [https://www.newscientist.com/author/claire-ainsworth/].   For more podcasts in this series, head to newscientist.com/podcasts [http://newscientist.com/podcasts] Learn more about your ad choices. Visit megaphone.fm/adchoices [https://megaphone.fm/adchoices]

Meet a woman who works at the frontlines of global nuclear monitoring. In this special series of New Scientist CoLab interviews, where we spotlight exceptional women driving progress in science, technology, engineering, and mathematics. Jenny is the leader of AWE’s forensic seismology team and Lead UN Inspector for the Comprehensive Nuclear Test Ban Treaty Organisation, which carries out large-scale inspections across the globe. She walks us through everything from what might prompt an inspection to what actually happens on the ground, highlighting just how complex these high-stakes missions are. We explore: ●      Jenny’s pioneering career at the intersection of science, security, and diplomacy ●      What skills are needed to work in high-stakes, global environments ●      Her advice for women looking to make a difference in STEM and international security This series is proudly sponsored by AWE [https://www.awe.co.uk/]. Your host is Claire Aisnworth [https://www.newscientist.com/author/claire-ainsworth/]. For more podcasts in this series, head to newscientist.com/podcasts [http://newscientist.com/podcasts] Learn more about your ad choices. Visit megaphone.fm/adchoices [https://megaphone.fm/adchoices]